Comparar métodos
Examine os métodos selecionados lado a lado; as linhas que diferem ficam destacadas.
| EORTC QLQ-BR23: Qualidade de Vida em Câncer de Mama× | Cancer Worry Scale× | |
|---|---|---|
| Área | Oncologia | Oncologia |
| Família | Process / pipeline | Process / pipeline |
| Ano de origem≠ | 1996 | 1991 |
| Autor original≠ | Sprangers, M. A., et al. (EORTC Quality of Life Group) | Lerman, C., et al. |
| Tipo | Self-report questionnaire | Self-report questionnaire |
| Fonte seminal≠ | Sprangers, M. A., Groenvold, M., Arraras, J. I., Franklin, J., te Velde, A., Muller, M., et al. (1996). The European Organization for Research and Treatment of Cancer breast cancer-specific quality-of-life questionnaire module: first results from a three-country field study. J Clin Oncol, 14(10), 2756–2768. DOI ↗ | Lerman, C., Trock, B., Rimer, B. K., Jepson, C., Brody, D., & Boyce, A. (1991). Psychological side effects of breast cancer screening. Health Psychol, 10(1), 259–267. DOI ↗ |
| Outros nomes | QLQ-BR23 | CWS |
| Relacionados | 5 | 5 |
| Resumo≠ | The EORTC QLQ-BR23 is a 23-item breast-cancer-specific module designed to complement the 30-item EORTC QLQ-C30 core questionnaire, assessing functional and symptom domains unique to breast cancer. Validated by Sprangers et al. in 1996, it measures body image, sexual function, breast symptoms, and arm symptoms, making it a standard instrument in European and international breast cancer clinical trials and quality-of-life research. | The Cancer Worry Scale (CWS) is a brief 8-item instrument assessing the degree to which cancer-related worry interferes with daily functioning and emotional well-being. Developed by Lerman et al. in 1991, it quantifies cancer-related anxiety and distress—psychological burden distinct from symptom burden and functional impairment. It is widely used in cancer screening, treatment, and survivorship contexts to identify patients requiring psychological support. |
| ScholarGateConjunto de dados ↗ |
|
|